Title: Refractory autoimmune thrombocytopenic purpura treatment with Rituximab
Abstract: American Journal of HematologyVolume 67, Issue 1 p. 59-60 Letters & CorrespondenceFree Access Refractory autoimmune thrombocytopenic purpura treatment with Rituximab Kashyap Patel, Kashyap Patel Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this authorJessica Berman, Jessica Berman Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this authorAndres Ferber, Andres Ferber Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this authorJaime Caro, Jaime Caro Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this author Kashyap Patel, Kashyap Patel Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this authorJessica Berman, Jessica Berman Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this authorAndres Ferber, Andres Ferber Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this authorJaime Caro, Jaime Caro Cardeza Foundation for Hematologic Research, Department of Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PennsylvaniaSearch for more papers by this author First published: 22 March 2001 https://doi.org/10.1002/ajh.1081Citations: 22AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994; 83: 435–445. 2McLaughlin P, Grillo-López AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of the patients responded to a four-dose treatment program. J Clin Oncol 1998; 16: 2825–2833. 3Perrota A, Sunneberg TA, Scott J, Ratanatharaphorn V, Hook C, Attas L, Dawson D, Kunkel LA. Rituxan in the treatment of chronic idiopathic thrombocytopenia purpura (ITP). Blood 1999; 94(Suppl 1): 14. 4Mow BM, Hook CC. Rituximab for the treatment of refractory immune thrombocytopenic purpura—case report. Blood 1999; 94(Suppl 1): 82b. 5Ratnatharathorn V, Carson E, Reynolds C, Ayesh LJ, Yanik G, Silver SM, Ferrara JL, Ubereti JP. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune mediated thrombocytopenia in a patient with chronic graft-versus-host disease. Ann Int Med 2000: 133:4: 275–279. Citing Literature Volume67, Issue1May 2001Pages 59-60 ReferencesRelatedInformation